Prisoners' Release: Buprenorphine

The Department for Health and Social Care (DHSC) funds local authorities to deliver drug and alcohol treatment services. Local authorities are responsible for commissioning drug and alcohol services according to local need, which includes the provision of Long-Acting Injectable Buprenorphine (LAIB), known under the brand name Buvidal. LAIB is available in all regions in England, including in County Durham and Easington, and for those who have been released from prison. It is a clinical decision whether to offer this treatment, based on an individual assessment and personal choice.

The Government has no current plans to ring-fence funding specifically for the provision of LAIB, and the Secretary of State for Justice has not held discussions with the Secretary of State for Health and Social Care on the provision of LAIB for people released from prison. The Ministry of Justice (MoJ) is committed to working with health partners to support access to clinical interventions appropriate to individual needs, and MoJ and DHSC work closely to ensure that people leaving prison receive continuity of care. We have a range of interventions to prepare prison leavers to continue their recovery journey in the community, including Health and Justice Partnership Coordinators nationwide, who strengthen links between prisons, probation and treatment providers.